Chinchem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.00 Cr
as on 24-10-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.00 Cr
as on 24-10-2024
- Revenue 4.64%
(FY 2023)
- Profit 97.49%
(FY 2023)
- Ebitda 56.13%
(FY 2023)
- Net Worth 1554.62%
(FY 2023)
- Total Assets 17.32%
(FY 2023)
About Chinchem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹23.00 Cr.
Omprakash Dhoot, Bina Dhoot, Arati Dhoot, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC201672
- Company No.
201672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chinchem Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Omprakash Dhoot  | Director | 05-Apr-2010 | Current |
| Bina Dhoot | Director | 05-Apr-2010 | Current |
| Arati Dhoot | Director | 05-Apr-2010 | Current |
| Nikhil Dhoot | Director | 05-Apr-2010 | Current |
Financial Performance and Corporate Structure Insights of Chinchem Laboratories.
Chinchem Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.64% increase. The company also saw a substantial improvement in profitability, with a 97.49% increase in profit. The company's net worth Soared by an impressive increase of 1554.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chinchem Laboratories?
In 2023, Chinchem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rotary Dombivli Downtown FoundationActive 1 month 13 daysArati Dhoot and Nikhil Dhoot are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tjsb Sahakari Bank Limited Creation Date: 11 Jun 2021 | ₹15.00 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 10 Jun 2021 | ₹8.00 Cr | Open |
How Many Employees Work at Chinchem Laboratories?
Unlock and access historical data on people associated with Chinchem Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chinchem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chinchem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
